Indi Molecular
Latest round
- Series A
Last raised
- Jun 2017
Total raised
- $13M
Investors
- 4
About Indi Molecular
Indi Molecular, Inc.Founded in 2013 and headquartered in Culver City, US, Indi Molecular specializes in oncology therapeutics. The company has undergone strategic developments but has not reported significant pivots.Indi Molecular specializes in the development of synthetic small molecule oncology therapeutics, notably targeting overexpressed folate receptors in ovarian cancer and KRAS G12D-expressing pancreatic cancers. Their primary offering includes Protein Catalyzed Capture (PCC) agents, engineered as peptide replacements for traditional antibody-based therapeutics. The PCC technology enables the creation of small peptides that exhibit pico-molar to low nano-molar binding affinities with enhanced cooperative binding, significantly improving therapeutic effectiveness. The company’s products are designed for efficient synthesis and robust manufacturing utilizing fully synthetic D-amino acids, which enhance stability and solubility while ensuring renal clearance.Indi Molecular generates revenue through the sale of its proprietary PCC agents to pharmaceutical companies, research institutions, and biotechnology firms engaged in oncology therapeutics. The company operates under a business-to-business (B2B) model, allowing clients to access its products through direct purchases or strategic partnerships. Transactions often involve contractual agreements detailing specific delivery timelines and performance metrics associated with the PCC agents. The company is focusing on upcoming PCC agents designed to enhance therapeutic efficacy in oncology, with targeted releases anticipated in the near term. Plans include geographical expansion into Europe and Asia by 2025, aiming to establish strategic partnerships with local healthcare providers and research institutions.
Who invested in Indi Molecular
4 investors across 3 rounds
See all investors in Indi Molecular
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Indi Molecular
Who invested in Indi Molecular?
Indi Molecular has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Indi Molecular raised?
Indi Molecular has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Indi Molecular last raise money?
Indi Molecular's most recent round on record is a Series A, in Jun 2017.
What does Indi Molecular do?
Indi Molecular is a biotechnology company.
Where is Indi Molecular headquartered?
Indi Molecular is headquartered in Culver City, US.
Which VCs invest in companies like Indi Molecular?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Indi Molecular's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Indi Molecular? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.